New consultations: shared care protocols for amiodarone and Sativex

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of two shared care protocols:

  • Amiodarone
  • Sativex

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the shared care protocols in NENC.

The consultations are open until 5pm on Sunday 30th April 2023 and can be accessed at https://ntag.nhs.uk/consultations/.  


New consultation: formulary amendments for February 2023

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Tuesday 4th April 2023. Take part by visiting the consultations page.


Consutation: NICE 30 day TA for eptinezumab

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on the implementation of a NICE 30 day TA, TA871: Eptinezumab for preventing migraine. Proposed formulary position and RAG status are outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for three weeks and closes at 5pm on Friday 24th March 2023. Take part by visiting the consultations page.


Consultation: NICE 30 day TA for upadacitinib

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on the implementation of a NICE 30 day TA, TA861: Upadacitinib for treating active non-radiographic axial spondyloarthritis. Proposed formulary position and RAG status are outlined in the consultation document.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for two weeks and closes at 5pm on Friday 24th February 2023. Take part by visiting the consultations page.


New consultation: formulary amendments for January 2023

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the proposed formulary amendments in a new consultation.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the decisions in NENC.

This consultation will run for four weeks and closes at 5pm on Friday 3rd March 2023. Take part by visiting the consultations page.


New consultation: shared care for dronedarone

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the North of Tyne Gateshead and North Cumbria shared care protocol for dronedarone, which is based on the national share care protocol for dronedarone.

Comments are welcomed from across the system, including residents and patients of the NENC. Comments will be returned to the medicines committee, or its sub-committee, and used to inform implementation of the shared care protocol in NENC.

This consultation will run for six weeks and closes at 5pm on Tuesday 14th March 2023..Take part by visiting the consultations page.


New consultation: shared care for valproate medicines

Update 05/01/2023: Consultation paused. The national valproate shared care protocol has been removed from the NHS England website, pending review and update in line the the recent MHRA Drug Safety Update. As a result, this consultation has been paused. See consultation page for more details.

Original news item: The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on adoption of the national shared care protocol for valproate medicines in patients of child-bearing potential.

Consultation comments will be used to inform implementation of the shared care protocol in NENC, and the NENC valproate project work.

The consultation will run until 5pm on Friday 20th January 2023. Take part by visiting the consultations page.


New consultation: NENC charter

The North East and North Cumbria (NENC) Medicines Committee are seeking NENC system-wide views on their draft charter, which attempts to couple the national and locally agreed medicines priorities and initiatives, and highlight the identified benefits this focussed activity will bring to the NENC integrated care system and its population.

This charter, once agreed by the medicines committee, will be submitted to the ICB executive as the key priorities for delivery by the medicines committee, its subcommittees and associated working groups. Metrics will be agreed and a dashboard will capture progress made, which in turn will support assurance reporting to the ICB. The charter is not intended to capture all medicines priorities, and it will continuously reviewed to ensure it remains current, but will be fully reviewed two years from approval. Comments are welcomed from across the system, including residents and patients of the North East and North Cumbria area.

The consultation is open until 5pm on Friday the 16th of December. To take part, visit the consultation page.